Svas Biosana S.p.A. (BIT:SVS)
Italy
· Delayed Price · Currency is EUR 8.50
+0.18 (2.16%)
At close: Dec 3, 2025
Svas Biosana Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 132.55 | 120.31 | 118.28 | 97.23 | 81.09 | 76.04 | Upgrade
|
| Other Revenue | 2.4 | 1.97 | 3.35 | 2.29 | 0.91 | 1.23 | Upgrade
|
| Revenue | 134.95 | 122.29 | 121.63 | 99.51 | 81.99 | 77.27 | Upgrade
|
| Revenue Growth (YoY) | 9.02% | 0.54% | 22.23% | 21.37% | 6.11% | -23.11% | Upgrade
|
| Cost of Revenue | 97.86 | 87.92 | 89.37 | 70.78 | 58.53 | 54.41 | Upgrade
|
| Gross Profit | 37.09 | 34.37 | 32.26 | 28.73 | 23.47 | 22.87 | Upgrade
|
| Selling, General & Admin | 17.37 | 16.43 | 15.64 | 16.84 | 11.02 | 11.39 | Upgrade
|
| Amortization of Goodwill & Intangibles | 2.14 | 1.9 | 1.79 | 1.81 | 1.76 | 1.33 | Upgrade
|
| Other Operating Expenses | 2.96 | 2.63 | 2.37 | -0 | 1.8 | 1.9 | Upgrade
|
| Operating Expenses | 26.06 | 24.56 | 23.69 | 22.45 | 17.69 | 17.77 | Upgrade
|
| Operating Income | 11.03 | 9.8 | 8.57 | 6.28 | 5.77 | 5.1 | Upgrade
|
| Interest Expense | -4.29 | -4.36 | -3.79 | -1.86 | -1.87 | -2.11 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.11 | 0.11 | 0.06 | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | -0.04 | 0.03 | -0.13 | -0.12 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.52 | 0.64 | 0.6 | 0.34 | 0.23 | 0.21 | Upgrade
|
| EBT Excluding Unusual Items | 7.39 | 6.16 | 5.51 | 4.68 | 4.02 | 3.22 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.73 | 1.85 | 1.29 | - | - | -0.01 | Upgrade
|
| Asset Writedown | - | - | - | -0.03 | - | - | Upgrade
|
| Pretax Income | 9.12 | 8.01 | 6.8 | 4.66 | 4.02 | 3.21 | Upgrade
|
| Income Tax Expense | 2.37 | 2.13 | 1.67 | 1.09 | 0.86 | 0.7 | Upgrade
|
| Earnings From Continuing Operations | 6.75 | 5.88 | 5.13 | 3.57 | 3.16 | 2.51 | Upgrade
|
| Net Income to Company | - | 5.88 | 5.13 | 3.57 | 3.16 | 2.51 | Upgrade
|
| Minority Interest in Earnings | -0 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
| Net Income | 6.74 | 5.87 | 5.12 | 3.57 | 3.16 | 2.51 | Upgrade
|
| Net Income to Common | 6.74 | 5.87 | 5.12 | 3.57 | 3.16 | 2.51 | Upgrade
|
| Net Income Growth | 23.68% | 14.68% | 43.52% | 12.97% | 25.70% | -34.17% | Upgrade
|
| Shares Outstanding (Basic) | - | 5 | - | 5 | - | - | Upgrade
|
| Shares Outstanding (Diluted) | - | 5 | - | 5 | - | - | Upgrade
|
| EPS (Basic) | - | 1.10 | - | 0.66 | - | - | Upgrade
|
| EPS (Diluted) | - | 1.10 | - | 0.66 | - | - | Upgrade
|
| Free Cash Flow | -4.33 | 1.42 | 0.52 | 1.9 | -0.08 | 10.45 | Upgrade
|
| Free Cash Flow Per Share | - | 0.27 | - | 0.35 | - | - | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | 0.300 | - | - | - | Upgrade
|
| Dividend Growth | -16.67% | -16.67% | - | - | - | - | Upgrade
|
| Gross Margin | 27.48% | 28.10% | 26.52% | 28.87% | 28.62% | 29.59% | Upgrade
|
| Operating Margin | 8.18% | 8.02% | 7.04% | 6.31% | 7.04% | 6.59% | Upgrade
|
| Profit Margin | 5.00% | 4.80% | 4.21% | 3.59% | 3.85% | 3.25% | Upgrade
|
| Free Cash Flow Margin | -3.21% | 1.17% | 0.43% | 1.91% | -0.10% | 13.52% | Upgrade
|
| EBITDA | 15.87 | 14.62 | 13.59 | 11.07 | 10.3 | 9.1 | Upgrade
|
| EBITDA Margin | 11.76% | 11.96% | 11.17% | 11.13% | 12.57% | 11.78% | Upgrade
|
| D&A For EBITDA | 4.84 | 4.82 | 5.02 | 4.79 | 4.53 | 4.01 | Upgrade
|
| EBIT | 11.03 | 9.8 | 8.57 | 6.28 | 5.77 | 5.1 | Upgrade
|
| EBIT Margin | 8.18% | 8.02% | 7.04% | 6.31% | 7.04% | 6.59% | Upgrade
|
| Effective Tax Rate | 26.02% | 26.63% | 24.60% | 23.31% | 21.33% | 21.69% | Upgrade
|
| Revenue as Reported | 134.68 | 122.77 | 122.34 | 102.28 | 81.52 | 77.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.